MIT LINCOLN LABORATORY - Lexington,ma since Jun 2002
-
ASSOCIATE STAFFFidelity Investments - Merrimack,NH Sep 2001 - May 2002
-
Oracle pl/sql programmerFluor - Lexington,MA Mar 1997 - Sep 2001
-
Oracle DBA/ProgrammerMonster - Framingham,MA Jul 1996 - Mar 1997
-
Oracle DBACommonwealth Gas Company - Southboro,MA Jul 1995 - Jul 1996
-
Systems AnalystMITRE - Bedford,MA Jun 1994 - Jul 1995
-
System AdministratorBay State Health Care - Cambridge,MA Jul 1989 - Jun 1994
-
Technical Analyst
Education:
Boston University - School of Management 1984 - 1989
MBA, MISNortheastern University 1977 - 1982
BSBA
Green Mountain Communications
since Jan 1998
-
Project Manager
Skills:
Zoning, Permitting, Construction Management, Testing, Site Development, Telecommunications, Budgeting, Wireless, Strategic Planning, Program Management
Dr. David B Sykes, Boston MA - MD (Doctor of Medicine)
Specialties:
Hematology, Hematology & Oncology
Age:
50
Address:
MASSACHUSETTS GENERAL HOSPITAL 55 Fruit St, Boston 02114 (617) 726-2000 (Phone), (617) 726-5715 (Fax) MASSACHUSETTS GENERAL HOSPITAL 55 Fruit St, Boston 02114 (617) 726-8705 (Phone), (617) 724-2710 (Fax) MASSACHUSETTS GENERAL HOSPITAL 55 Fruit St, Boston 02114 (617) 726-2000 (Phone), (617) 726-7474 (Fax) MASSACHUSETTS GENERAL HOSPITAL 55 Fruit St, Boston 02114 (617) 726-2000 (Phone), (617) 724-5843 (Fax) Massachusetts Gen Hosp Cncr Ctr 55 Fruit St, Boston 02114 (617) 724-4000 (Phone)
Languages:
English
Hospitals:
MASSACHUSETTS GENERAL HOSPITAL 55 Fruit St, Boston 02114 MASSACHUSETTS GENERAL HOSPITAL 55 Fruit St, Boston 02114 MASSACHUSETTS GENERAL HOSPITAL 55 Fruit St, Boston 02114 MASSACHUSETTS GENERAL HOSPITAL 55 Fruit St, Boston 02114 Massachusetts Gen Hosp Cncr Ctr 55 Fruit St, Boston 02114 Dana - Farber Cancer Institute 450 Brookline Ave, Boston 02115
Education:
Medical School Univ Of Ca Graduated: 2001 Massachusetts General Hospital Dana Farber Cancer Institute
A method to generate unlimited numbers of macrophage/dendritic cells or neutrophils from mice, using conditional Hox oncoproteins is disclosed. The invention further includes the establishment of a system to investigate immune responses to microorganisms or diseases involving chronic inflammation.